Hisashi Mitsuguchi
Auditor @ DBJ Capital
Hisashi Mitsuguchi is a Series A investor at DBJ Capital focused on Biotechnology and Pharmaceutical. Hisashi Mitsuguchi
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Hisashi Mitsuguchi invests in
Stages Hisashi Mitsuguchi invests in
Countries Hisashi Mitsuguchi invests in
Investment Focus
Industry
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
- Clinical Trials 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Alivexis
|
Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus iscomprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms. | $113.4M / Series A / Aug 09, 2018 |
Co-Investors
About DBJ Capital
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
DBJ Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Akama Sho
Senior Investment Manager
|
|||
|
Daiki Ito
Investment Manager
|
|||
Haruhiko Uchiyama
President and CEO
|
|||
|
Hisashi Mitsuguchi
Auditor
|
|||
|
Shingo Isobe
Senior Investment Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hisashi Mitsuguchi invest in?
Hisashi Mitsuguchi invests primarily in Biotechnology, Pharmaceutical and Clinical Trials startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hisashi Mitsuguchi last invest?
The most recent investment recorded for Hisashi Mitsuguchi closed in Aug 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
